Baxter International (BAX) Total Current Liabilities (2009 - 2026)
Baxter International (BAX) reported Total Current Liabilities of $3.7 billion for Q1 2026, up 6.09% year-over-year from $3.5 billion in Q1 2025, and up 24.34% quarter-over-quarter from $3.0 billion in Q4 2025.
Baxter International (BAX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Total Current Liabilities data on file, last reported at $3.7 billion in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $3.7 billion, up 6.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 6.09% YoY), and the FY2025 annual result was $3.0 billion, down 54.38% from the prior year.
- Total Current Liabilities climbed to $3.7 billion in Q1 2026 per BAX's latest filing, from $3.0 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $6.5 billion in Q4 2024 and troughed at $2.9 billion in Q2 2025.
- A 5-year average of $4.8 billion and a median of $4.7 billion in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities jumped 67.45% in 2023, then plunged 54.38% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $4.7 billion in 2022, then surged by 37.05% to $6.5 billion in 2023, then grew by 0.12% to $6.5 billion in 2024, then sank by 54.38% to $3.0 billion in 2025, then gained by 24.34% to $3.7 billion in 2026.
- Business Quant data shows BAX's Total Current Liabilities at $3.7 billion in Q1 2026, $3.0 billion in Q4 2025, and $3.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.69 Bn |
| Dec 31, 2025 | 2.97 Bn |
| Sep 30, 2025 | 3.78 Bn |
| Jun 30, 2025 | 2.94 Bn |
| Mar 31, 2025 | 3.48 Bn |
| Dec 31, 2024 | 6.51 Bn |
| Sep 30, 2024 | 6.20 Bn |
| Jun 30, 2024 | 6.13 Bn |
| Mar 31, 2024 | 6.37 Bn |
| Dec 31, 2023 | 6.50 Bn |
| Sep 30, 2023 | 6.21 Bn |
| Jun 30, 2023 | 5.77 Bn |
| Mar 31, 2023 | 4.76 Bn |
| Dec 31, 2022 | 4.75 Bn |
| Sep 30, 2022 | 3.71 Bn |
| Jun 30, 2022 | 3.92 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.24 Bn |
| Sep 30, 2021 | 3.44 Bn |
| Jun 30, 2021 | 3.34 Bn |